179 related articles for article (PubMed ID: 666743)
1. The availability of inorganic sulphate in blood for sulphate conjugation of drugs in rat liver in vivo. (35S)Sulphate incorporation into harmol sulphate.
Mulder GJ; Scholtens E
Biochem J; 1978 May; 172(2):247-51. PubMed ID: 666743
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of inorganic sulphate in the isolated perfused rat liver. Effect of sulphate concentration on the rate of sulphation by phenol sulphotransferase.
Mulder GJ; Keulemans K
Biochem J; 1978 Dec; 176(3):959-65. PubMed ID: 747664
[TBL] [Abstract][Full Text] [Related]
3. Biliary and urinary excretion of drug conjugates: effect of diuresis and choleresis on excretion of harmol sulphate and harmol glucuronide in the rat.
Jorritsma J; Meerman JH; Vonk RJ; Mulder GJ
Xenobiotica; 1979 Apr; 9(4):247-52. PubMed ID: 483860
[TBL] [Abstract][Full Text] [Related]
4. Secretion of the organic anion harmol sulfate from liver into blood. Evidence for a carrier-mediated mechanism.
de Vries MH; Groothuis GM; Mulder GJ; Nguyen H; Meijer DK
Biochem Pharmacol; 1985 Jun; 34(12):2129-35. PubMed ID: 4004931
[TBL] [Abstract][Full Text] [Related]
5. The dependence of the rate of sulphate conjugation on the plasma concentration of inorganic sulphate in the rat in vivo.
Krijgsheld KR; Scholtens E; Mulder GJ
Biochem Pharmacol; 1982 Dec; 31(24):3997-4000. PubMed ID: 7159477
[TBL] [Abstract][Full Text] [Related]
6. Sulphate and glucuronic acid conjugation of harmol in human fetal and adult liver tissue.
Steiner E; von Bahr C; Rane A
Dev Pharmacol Ther; 1982; 5(1-2):14-20. PubMed ID: 7151633
[TBL] [Abstract][Full Text] [Related]
7. Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate.
Krijgsheld KR; Koster HJ; Scholtens E; Mulder GJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):731-4. PubMed ID: 7086685
[TBL] [Abstract][Full Text] [Related]
8. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ; Stillwell RN
J Pharmacol Exp Ther; 1983 Mar; 224(3):647-53. PubMed ID: 6827487
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of sulfation and glucuronidation of harmol in the perfused rat liver preparation. Disappearance of aberrances in glucuronidation kinetics by inhibition of sulfation.
Koster H; Halsema I; Scholtens E; Pang KS; Mulder GJ
Biochem Pharmacol; 1982 Oct; 31(19):3023-8. PubMed ID: 7150332
[TBL] [Abstract][Full Text] [Related]
10. Sulphation of the flavonoids quercetin and catechin by rat liver.
Shali NA; Curtis CG; Powell GM; Roy AB
Xenobiotica; 1991 Jul; 21(7):881-93. PubMed ID: 1776264
[TBL] [Abstract][Full Text] [Related]
11. UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro--IV. Species differences in harmol conjugation and elimination in bile and urine in vivo.
Mulder GJ; Bleeker B
Biochem Pharmacol; 1975 Aug; 24(16):1481-4. PubMed ID: 811225
[No Abstract] [Full Text] [Related]
12. Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes.
Sundheimer DW; Brendel K
Drug Metab Dispos; 1983; 11(5):433-40. PubMed ID: 6138228
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia impairs conjugation and elimination of harmol in the isolated perfused rat liver.
Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
J Pharmacol Exp Ther; 1987 Mar; 240(3):931-6. PubMed ID: 3559985
[TBL] [Abstract][Full Text] [Related]
14. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations.
Pang KS; Koster H; Halsema IC; Scholtens E; Mulder GJ
J Pharmacol Exp Ther; 1981 Oct; 219(1):134-40. PubMed ID: 7288601
[No Abstract] [Full Text] [Related]
16. Synergistic effects of hypoxia and fasting on harmol elimination in the isolated perfused rat liver.
Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
Biochem Pharmacol; 1988 Apr; 37(7):1207-12. PubMed ID: 3355595
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous distribution of conjugation activities of harmol in isolated rat liver cells.
Araya H; Mizuma T; Horie T; Hayashi M; Awazu S
J Pharmacobiodyn; 1984 Sep; 7(9):624-9. PubMed ID: 6098639
[TBL] [Abstract][Full Text] [Related]
18. Uptake of glucuronides into isolated hepatocytes and their effects on glucuronide and sulphate conjugation.
Norling A; Andersson B; Berggren M; Moldéus P
Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):311-7. PubMed ID: 716948
[TBL] [Abstract][Full Text] [Related]
19. Quantitative studies of sulphate conjugation by isolated rat liver cells using [35S]sulphate.
Dawson J; Knowles RG; Pogson CI
Biochem Pharmacol; 1991 Jun; 42(1):45-9. PubMed ID: 2069597
[TBL] [Abstract][Full Text] [Related]
20. Extrahepatic sulfation and glucuronidation in the rat in vivo. Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation.
Mulder GJ; Weitering JG; Scholtens E; Dawson JR; Pang KS
Biochem Pharmacol; 1984 Oct; 33(19):3081-7. PubMed ID: 6487358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
